Trends in Incidence and Survivals for Ovarian Germ Cell Tumors: A 27-Year Population-Based Study

This study has been withdrawn prior to enrollment.
(The study was limited to IRB Exempt chart review; not an applicable trial.)
Sponsor:
Information provided by (Responsible Party):
New Mexico Cancer Care Alliance
ClinicalTrials.gov Identifier:
NCT00323726
First received: May 5, 2006
Last updated: June 16, 2015
Last verified: June 2015
  Purpose
Trends in Incidence and Survivals for Ovarian Germ Cell Tumors: A 27-Year Population-Based Study

Condition
Ovarian Cancer

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: Trends in Incidence and Survivals for Ovarian Germ Cell Tumors: A 27-Year Population-Based Study

Resource links provided by NLM:


Further study details as provided by New Mexico Cancer Care Alliance:

Enrollment: 0
Study Start Date: December 2005
Study Completion Date: December 2006
Primary Completion Date: December 2006 (Final data collection date for primary outcome measure)
Detailed Description:
This is a chart review.
  Eligibility

Ages Eligible for Study:   Child, Adult, Senior
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients with ovarian germ cell tumors
Criteria

Inclusion Criteria:

  • Patients with Ovarian Germ Cell Tumors in the last 27 years.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00323726

Locations
United States, New Mexico
University of New Mexico
Albuquerque, New Mexico, United States, 87131
Sponsors and Collaborators
New Mexico Cancer Care Alliance
Investigators
Principal Investigator: Harriet Smith, MD University of New Mexico
  More Information

Responsible Party: New Mexico Cancer Care Alliance
ClinicalTrials.gov Identifier: NCT00323726     History of Changes
Other Study ID Numbers: HRRC 02-579 
Study First Received: May 5, 2006
Last Updated: June 16, 2015
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Neoplasms, Germ Cell and Embryonal
Germinoma
Ovarian Neoplasms
Neoplasms by Histologic Type
Neoplasms
Endocrine Gland Neoplasms
Neoplasms by Site
Ovarian Diseases
Adnexal Diseases
Genital Diseases, Female
Genital Neoplasms, Female
Urogenital Neoplasms
Endocrine System Diseases
Gonadal Disorders

ClinicalTrials.gov processed this record on July 21, 2016